Articles tagged "Liver transplantation"

2022 American Transplant Congress
Assessing Safety of Using ECMO-Supported Donors in Abdominal Transplantation
P. J. Altshuler¹, A. P. Shah¹, J. M. Glorioso¹, W. R. Maley¹, A. M. Frank¹, C. B. Ramirez¹, H. Dang¹, S. West², R. Hasz, Jr.², A. S. Bodzin¹
¹Department of Surgery, Thomas Jefferson University, Philadelphia, PA, ²Gift Of Life Donor Program, Philadelphia, PA
*Purpose: Organ donors supported by extracorporeal membrane oxygenation (ECMO) are historically considered high-risk and are judiciously utilized. Here we explore the safety of using organs…
2022 American Transplant Congress
Long-Term Follow Up of Solid Organ Transplantation Using Hepatitis C Virus Positive Donor for Hepatitis C Virus Negative Recipients
H. Sogawa¹, I. Lee², K. Okumura³, R. Bodin⁴, D. C. Wolf⁴, B. Partiula⁴, A. Dhand⁴, M. Kai⁵, S. Ohira⁵, R. Misawa¹, G. Veillette⁶, D. John¹, S. Nishida⁷, T. Diflo⁶
¹Division of Intra-abdominal Organ Transplant, Department of Surgery, Westchester Medical Center/ New York Medical College, Valhalla, NY, ²Department of Surgery, Westchester Medical Center/ New York Medical College, Valhalla, NY, ³Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY, ⁴Department of Medicine, Westchester Medical Center/ New York Medical College, Valhalla, NY, ⁵Cardiothoracic Surgery, Westchester Medical Center/ New York Medical College, Valhalla, NY, ⁶Westchester Medical Center, Valhalla, NY, ⁷Westchester Medical Center/ New York Medical College, Valhalla, NY
*Purpose: To determine the effects of transplanting an HCV + solid organ to an uninfected patient who is on the transplant waiting list. Outcomes include…
2022 American Transplant Congress
Pure Laparoscopic versus Open Right Hepatectomy in Living Liver Donors (Graft Weight Discrepancy)
J. Seo¹, S. Hong¹, S. Lee², S. Suh², S. Hong¹, E. Han¹, Y. Choi², N. Yi², K. Lee³, K. Suh¹
¹Surgery, Seoul National University College of Medicine, Seoul, Korea, Republic of, ²Seoul National University College of Medicine, Seoul, Korea, Republic of, ³Seoul National University, Seoul, Korea, Republic of
*Purpose: The studies of volumetric evaluation in pure laparoscopic donor hepatectomy (PLDH) are relatively less known than that of conventional donor hepatectomy. The aim of…
2022 American Transplant Congress
Single Cell RNAseq Analysis of Liver Transplant Rejection Reveals Highly Restricted TCR Clonal Expansion of Tissue-Resident Memory CD8⁺ T Cells That Persist Despite Corticosteroids and ATG Therapy
A. L. Peters¹, G. Begum¹, K. Roskin², E. Woodle³, D. Hildeman⁴
¹Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²Department of Bioinformatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³Department of Surgery, University of Cincinnati, Cincinnati, OH, ⁴Department of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
*Purpose: Conventional therapy for liver transplant rejection (corticosteroids and ATG) has remained unchanged for six decades, and is not infrequently met with treatment failure. Here,…
2022 American Transplant Congress
Variation in Donor Liver Rejection Rates for Donor Quality Among US Transplant Centers
M. Anderson¹, T. Gilbert², M. Englesbe¹, S. Waits¹
¹Michigan Medicine Transplant Center, Ann Arbor, MI, ²University of Michigan Medical School, Ann Arbor, MI
*Purpose: Optimal utilization of all viable donor livers is a public health imperative. As no standardized criteria exist for assessment of donor quality, differential utilization…
2022 American Transplant Congress
Impaired Left Ventricular Global Longitudinal Strain: Clinical Presentation and Outcomes in Liver Transplantation Recipients without Arrhythmia or Structural Heart Disease
M. B. Hammami, J. Grossman, P. Xue, H. Allaham, K. Eagan, S. Gottlieb, C. Hong, L. Wang, C. Bhati, D. Maluf, K. Shetty, N. Urrunaga
University of Maryland School of Medicine, Baltimore, MD
*Purpose: Assess the prevalence and characteristics of patients without arrhythmia or structural heart disease (SHD) but with impaired pre-transplant left ventricular global longitudinal strain (GLS)…
2022 American Transplant Congress
Area Deprivation Index is Associated with Worse Patient Survival Following Adult Liver Transplantation
J. Hendele¹, J. Perkins², J. Nichols³, A. Dick¹
¹Division of Transplant Surgery, Department of Surgery, University of Washington, Seattle, WA, ²Clinical and Bio-Analytics Transplant Laboratory (CBATL), University of Washington, Division of Transplant Surgery, Department of Surgery, Seattle, WA, ³School of Medicine, University of Washington, Seattle, WA
*Purpose: Area Deprivation Index (ADI) has been utilized as a granular measure of local socioeconomic status for nearly two decades. This study is the first…
2022 American Transplant Congress
Escalating Waitlist Mortality Above MELD 40: A Rationale to Uncap MELD 3.0?
A. Kwong, A. Mannalithara, W. Kim
Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA
*Purpose: MELD 3.0 is a recently proposed model that improves upon MELD-Na, incorporating sex and albumin as additional variables, updating existing coefficients and adding relevant…
2022 American Transplant Congress
Impact of MMaT Policy on Transplant for Hepatocellular Carcinoma at a Single Center
S. Kodali¹, D. W. Victor², J. Corkrean², A. Shetty², C. Mobley², M. Hobeika², R. McMillan², E. A. Graviss³, D. T. Nguyen³, R. McFadden⁴, V. Ankoma-Sey², C. Egwim⁵, J. Galati², A. Saharia², R. M. Ghobrial²
¹Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Sugarland, TX, ²Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Houston, TX, ³Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, ⁴Department of Medicine, Hepatology, Houston Methodist Hospital, Houston, TX, ⁵Houston Methodist Hospital, Houston, TX
*Purpose: Hepatocellular carcinoma (HCC) is the most common primary malignant hepatic tumor. Currently, liver transplantation may be the optimal treatment for HCC. Patient selection criteria…
2022 American Transplant Congress
Fontan versus Non-Fontan Combined Heart-Liver Transplantation: Proceed but Cautiously
I. A. Ziogas, W. K. Wu, M. Izzy, A. Shingina, C. Benson, K. L. Mishra, A. S. Shah, N. L. Do, W. G. McMaster, J. N. Menachem, S. P. Alexopoulos
Vanderbilt University Medical Center, Nashville, TN
*Purpose: Combined heart-liver transplantation (CHLT) is increasing, corresponding with a growing prevalence of Fontan-associated end-organ damage. We aimed to describe our contemporary institutional experience with…